877 related articles for article (PubMed ID: 19527933)
21. Synthesis, antitumor activity and molecular docking study of novel benzofuran-2-yl pyrazole pyrimidine derivatives.
El-Zahar MI; Adb El-Karim SS; Haiba ME; Khedr MA
Acta Pol Pharm; 2011; 68(3):357-73. PubMed ID: 21648190
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and antiproliferative evaluation of pyrazolo[1,5-a]-1,3,5-triazine myoseverin derivatives.
Popowycz F; Schneider C; Debonis S; Skoufias DA; Kozielski F; Galmarini CM; Joseph B
Bioorg Med Chem; 2009 May; 17(9):3471-8. PubMed ID: 19349183
[TBL] [Abstract][Full Text] [Related]
23. 5-N-Substituted-2-(substituted benzenesulphonyl) glutamines as antitumor agents. Part II: synthesis, biological activity and QSAR study.
Samanta S; Srikanth K; Banerjee S; Debnath B; Gayen S; Jha T
Bioorg Med Chem; 2004 Mar; 12(6):1413-23. PubMed ID: 15018914
[TBL] [Abstract][Full Text] [Related]
24. Design and QSAR study of analogs of gamma-tocotrienol with enhanced antiproliferative activity against human breast cancer cells.
Nikolic K; Agababa D
J Mol Graph Model; 2009 Apr; 27(7):777-83. PubMed ID: 19117779
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of new pyrazolo[5,1-c][1,2,4] benzotriazines, pyrazolo[5,1-c]pyrido[4,3-e][1,2,4] triazines and their open analogues as cytotoxic agents in normoxic and hypoxic conditions.
Ciciani G; Coronnello M; Guerrini G; Selleri S; Cantore M; Failli P; Mini E; Costanzo A
Bioorg Med Chem; 2008 Nov; 16(21):9409-19. PubMed ID: 18845441
[TBL] [Abstract][Full Text] [Related]
26. Anticancer activity of selected phenolic compounds: QSAR studies using ridge regression and neural networks.
Nandi S; Vracko M; Bagchi MC
Chem Biol Drug Des; 2007 Nov; 70(5):424-36. PubMed ID: 17949360
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and evaluation of 3,4-disubstituted pyrazole analogues as anti-tumor CDK inhibitors.
Lin R; Chiu G; Yu Y; Connolly PJ; Li S; Lu Y; Adams M; Fuentes-Pesquera AR; Emanuel SL; Greenberger LM
Bioorg Med Chem Lett; 2007 Aug; 17(16):4557-61. PubMed ID: 17574416
[TBL] [Abstract][Full Text] [Related]
28. New synthesis of two tridentate bipyrazolic compounds and their cytotoxic activity tumor cell lines.
El Kodadi M; Benamar M; Ibrahim B; Zyad A; Malek F; Touzani R; Ramdani A; Melhaoui A
Nat Prod Res; 2007 Sep; 21(11):947-52. PubMed ID: 17691042
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of 2-(methylaminosulfonyl)-1-(arylsulfonyl)hydrazines as anticancer agents.
Ghosh M; Dutta S; Sanyal U
Neoplasma; 1999; 46(4):242-5. PubMed ID: 10613605
[TBL] [Abstract][Full Text] [Related]
30. Pyrazolobenzodiazepines: part I. Synthesis and SAR of a potent class of kinase inhibitors.
Liu JJ; Daniewski I; Ding Q; Higgins B; Ju G; Kolinsky K; Konzelmann F; Lukacs C; Pizzolato G; Rossman P; Swain A; Thakkar K; Wei CC; Miklowski D; Yang H; Yin X; Wovkulich PM
Bioorg Med Chem Lett; 2010 Oct; 20(20):5984-7. PubMed ID: 20832307
[TBL] [Abstract][Full Text] [Related]
31. Novel Biginelli dihydropyrimidines with potential anticancer activity: a parallel synthesis and CoMSIA study.
Prashantha Kumar BR; Sankar G; Nasir Baig RB; Chandrashekaran S
Eur J Med Chem; 2009 Oct; 44(10):4192-8. PubMed ID: 19525040
[TBL] [Abstract][Full Text] [Related]
32. Identification of novel 3,5-diarylpyrazoline derivatives containing salicylamide moiety as potential anti-melanoma agents.
Li QS; Lv XH; Zhang YB; Dong JJ; Zhou WP; Yang Y; Zhu HL
Bioorg Med Chem Lett; 2012 Nov; 22(21):6596-601. PubMed ID: 23025996
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and anti-tumor activities of novel pyrazolo[1,5-a]pyrimidines.
Li J; Zhao YF; Zhao XL; Yuan XY; Gong P
Arch Pharm (Weinheim); 2006 Nov; 339(11):593-7. PubMed ID: 17036367
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and anticancer evaluation of novel tetrahydroquinoline derivatives containing sulfonamide moiety.
Ghorab MM; Ragab FA; Hamed MM
Eur J Med Chem; 2009 Oct; 44(10):4211-7. PubMed ID: 19540022
[TBL] [Abstract][Full Text] [Related]
35. Novel modified steroid derivatives of androstanolone as chemotherapeutic anti-cancer agents.
El-Far M; Elmegeed GA; Eskander EF; Rady HM; Tantawy MA
Eur J Med Chem; 2009 Oct; 44(10):3936-46. PubMed ID: 19447526
[TBL] [Abstract][Full Text] [Related]
36. Relationship between the chemical structures and biological activities (toxicity, mutagenic and antitumor) in newly synthesized derivatives of pyrazolo pyrimidines.
Nersesyan A; Muradyan R; Arsenyan F; Danagulyan G
Tsitol Genet; 2006; 40(6):28-32. PubMed ID: 17243373
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, anticancer, and cytotoxic activities of some mononuclear Ru(II) compounds.
Karki SS; Thota S; Darj SY; Balzarini J; De Clercq E
Bioorg Med Chem; 2007 Nov; 15(21):6632-41. PubMed ID: 17765549
[TBL] [Abstract][Full Text] [Related]
38. 1-Methyl-3H-pyrazolo[1,2-a]benzo[1,2,3,4]tetrazin-3-ones. Design, synthesis, and biological activity of new antitumor agents.
Almerico AM; Mingoia F; Diana P; Barraja P; Lauria A; Montalbano A; Cirrincione G; Dattolo G
J Med Chem; 2005 Apr; 48(8):2859-66. PubMed ID: 15828824
[TBL] [Abstract][Full Text] [Related]
39. Novel cyano- and amidinobenzothiazole derivatives: synthesis, antitumor evaluation, and X-ray and quantitative structure-activity relationship (QSAR) analysis.
Caleta I; Kralj M; Marjanović M; Bertosa B; Tomić S; Pavlović G; Pavelić K; Karminski-Zamola G
J Med Chem; 2009 Mar; 52(6):1744-56. PubMed ID: 19265399
[TBL] [Abstract][Full Text] [Related]
40. Cyclocondensation reaction of heterocyclic carbonyl compounds. Part XIII: synthesis and cytotoxic activity of some 3,7-diaryl-5-(3,4,5-trimethoxyphenyl)pyrazolo[4,3-e][1,2,4]triazines.
Gucký T; Frysová I; Slouka J; Hajdúch M; Dzubák P
Eur J Med Chem; 2009 Feb; 44(2):891-900. PubMed ID: 18632190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]